{"id":"https://openalex.org/W7223147188","doi":"https://doi.org/10.1016/j.htct.2026.107933","title":"SEROLOGICAL SCREENING IN MULTIPLE MYELOMA: UNCOVERING IMMUNIZATION GAPS AND LATENT INFECTION RISK IN THE ERA OF IMMUNOTHERAPIES","display_name":"SEROLOGICAL SCREENING IN MULTIPLE MYELOMA: UNCOVERING IMMUNIZATION GAPS AND LATENT INFECTION RISK IN THE ERA OF IMMUNOTHERAPIES","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223147188","doi":"https://doi.org/10.1016/j.htct.2026.107933"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.107933","doi":"https://doi.org/10.1016/j.htct.2026.107933","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107933","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926016809/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S2531137926016809/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159213255","display_name":"Ully Barbosa DA COSTA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ully Barbosa DA COSTA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159186234","display_name":"Juliana Pessoa RIVELLO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliana Pessoa RIVELLO","raw_affiliation_strings":["Proc\u00e9lula, Grupo Pulsa, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proc\u00e9lula, Grupo Pulsa, Rio de Janeiro, RJ, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159191206","display_name":"Gleyce de Freitas Mattos EXPEDITO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267500","display_name":"Complexo Hospitalar de Niter\u00f3i","ror":"https://ror.org/0318w6p08","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4405267500"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gleyce de Freitas Mattos EXPEDITO","raw_affiliation_strings":["Complexo Hospitalar Niter\u00f3i, Am\u00e9ricas, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Complexo Hospitalar Niter\u00f3i, Am\u00e9ricas, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4405267500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159220584","display_name":"Luiz Fernando Xavier DA COSTA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luiz Fernando Xavier DA COSTA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159201310","display_name":"Simone Cunha MARADEI","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267500","display_name":"Complexo Hospitalar de Niter\u00f3i","ror":"https://ror.org/0318w6p08","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4405267500"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Simone MARADEI","raw_affiliation_strings":["Complexo Hospitalar Niter\u00f3i, Am\u00e9ricas, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Complexo Hospitalar Niter\u00f3i, Am\u00e9ricas, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4405267500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028621526","display_name":"Jacques Kaufman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267500","display_name":"Complexo Hospitalar de Niter\u00f3i","ror":"https://ror.org/0318w6p08","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4405267500"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Jacques KAUFMAN","raw_affiliation_strings":["Complexo Hospitalar Niter\u00f3i, Am\u00e9ricas, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Complexo Hospitalar Niter\u00f3i, Am\u00e9ricas, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4405267500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159206207","display_name":"Angelo MAIOLINO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Angelo MAIOLINO","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro e Instituto Am\u00e9ricas, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro e Instituto Am\u00e9ricas, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5159192392","display_name":"Marcia GARNICA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]},{"id":"https://openalex.org/I4405267500","display_name":"Complexo Hospitalar de Niter\u00f3i","ror":"https://ror.org/0318w6p08","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4405267500"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Marcia GARNICA","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro e Complexo Hospitalar Niter\u00f3i, Am\u00e9ricas, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro e Complexo Hospitalar Niter\u00f3i, Am\u00e9ricas, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I122140584","https://openalex.org/I4405267500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.80074242,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"107933","last_page":"107933"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/serological-screening","display_name":"serological screening","score":0.9409999847412109},{"id":"https://openalex.org/keywords/cytomegalovirus","display_name":"cytomegalovirus","score":0.781000018119812},{"id":"https://openalex.org/keywords/hepatitis-b","display_name":"hepatitis B","score":0.753000020980835},{"id":"https://openalex.org/keywords/hepatitis-c","display_name":"hepatitis C","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.7369999885559082},{"id":"https://openalex.org/keywords/syphilis","display_name":"syphilis","score":0.8360000252723694},{"id":"https://openalex.org/keywords/chagas-disease","display_name":"Chagas disease","score":0.8970000147819519},{"id":"https://openalex.org/keywords/htlv","display_name":"HTLV","score":0.9829999804496765},{"id":"https://openalex.org/keywords/anti-cd38-therapy","display_name":"anti-CD38 therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9070000052452087},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.5490000247955322},{"id":"https://openalex.org/keywords/vaccine-induced-immunity","display_name":"vaccine-induced immunity","score":0.5839999914169312},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.4959999918937683},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.43799999356269836},{"id":"https://openalex.org/keywords/infection-control","display_name":"infection control","score":0.5860000252723694},{"id":"https://openalex.org/keywords/seroprevalence","display_name":"seroprevalence","score":0.6060000061988831},{"id":"https://openalex.org/keywords/brazil","display_name":"Brazil","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9699000120162964},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.7451000213623047},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.7057999968528748},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5446000099182129},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4690999984741211},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.37220001220703125},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.31450000405311584},{"id":"https://openalex.org/C3019879152","wikidata":"https://www.wikidata.org/wiki/Q2712836","display_name":"Infection risk","level":2,"score":0.30889999866485596},{"id":"https://openalex.org/C2776272983","wikidata":"https://www.wikidata.org/wiki/Q7336291","display_name":"Risk of infection","level":2,"score":0.304500013589859},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.2903999984264374},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.2896000146865845},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.2524999976158142}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.107933","doi":"https://doi.org/10.1016/j.htct.2026.107933","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107933","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926016809/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:eef3f478af8b4cd28ece11721f1675ac","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/eef3f478af8b4cd28ece11721f1675ac","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 107933- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.107933","doi":"https://doi.org/10.1016/j.htct.2026.107933","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107933","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926016809/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223147188.pdf","grobid_xml":"https://content.openalex.org/works/W7223147188.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2980458142","https://openalex.org/W4392165755","https://openalex.org/W2588397113","https://openalex.org/W2136778441","https://openalex.org/W2554010527","https://openalex.org/W2760065417","https://openalex.org/W4417021143","https://openalex.org/W7161967557","https://openalex.org/W3107483113","https://openalex.org/W2998137655"],"abstract_inverted_index":{"Background":[0],"Patients":[1],"with":[2,103,124,158,179,229,255,369,377],"multiple":[3],"myeloma":[4],"(MM)":[5],"are":[6],"at":[7,393],"increased":[8],"risk":[9,109,411],"of":[10,15,26,50,71,80,98,106,183,201,233,245,253,329,334,358,389,416],"infection":[11,424],"across":[12,413],"all":[13,414],"phases":[14,415],"the":[16,24,47,77,104,111,169,202,332,339,355,364,406],"disease,":[17,144],"from":[18],"diagnosis":[19],"to":[20,82,276,408],"relapse,":[21],"particularly":[22],"in":[23,37,58,95,251,363],"era":[25],"novel":[27],"therapies.":[28],"Mapping":[29],"prior":[30,164],"infectious":[31,90,410],"exposure":[32,81],"is":[33],"a":[34,68,96,180,236,361,386],"fundamental":[35],"step":[36],"planning":[38],"prophylaxis,":[39,422],"immunization,":[40],"and":[41,88,131,139,145,160,188,212,226,317,400,423],"event":[42],"monitoring.":[43],"Brazilian":[44],"data":[45],"describing":[46],"serological":[48,78,93,154],"profile":[49,79,155],"this":[51,72],"population":[52],"remain":[53],"scarce;":[54],"however,":[55],"mandatory":[56],"screening":[57,94,150],"patients":[59,100,123,173,288,297,368],"undergoing":[60,101],"autologous":[61],"hematopoietic":[62],"cell":[63],"transplantation":[64],"(HCT)":[65],"may":[66],"provide":[67],"representative":[69],"picture":[70],"epidemiology.":[73],"Aim":[74],"To":[75],"characterize":[76],"hepatotropic":[83],"viruses,":[84],"cytomegalovirus":[85],"(CMV),":[86],"HIV,":[87,141,266],"other":[89],"agents":[91],"through":[92],"cohort":[97],"MM":[99,125,417],"HCT,":[102],"aim":[105],"mapping":[107],"infection/reactivation":[108],"throughout":[110],"disease":[112],"course.":[113],"Methods":[114],"This":[115],"was":[116,156,249,312,326],"an":[117],"observational,":[118],"retrospective,":[119],"single-center":[120],"study":[121,170],"including":[122,385],"who":[126],"underwent":[127,174],"HCT":[128],"between":[129,314],"2023":[130],"2025.":[132],"Serology":[133],"results":[134,196],"for":[135,199,223,265,367,379,397],"CMV,":[136],"hepatitis":[137,218,335,350,398],"B":[138,336,351,399],"C,":[140],"syphilis,":[142,267],"Chagas":[143,270],"HTLV":[146],"obtained":[147],"during":[148,354,381],"pre-HCT":[149],"were":[151,177,197,209,214,221,263],"analyzed.":[152],"The":[153],"correlated":[157],"demographic":[159],"clinical":[161],"variables":[162],"(including":[163],"anti-CD38":[165],"use).":[166],"Results":[167],"During":[168],"period,":[171],"123":[172],"HCT;":[175],"50.4%":[176],"female,":[178],"median":[181],"age":[182,318,330],"60":[184],"years":[185],"(range,":[186],"26\u201375),":[187],"45%":[189],"had":[190,235,240],"received":[191],"anti-CD38-based":[192],"regimens.":[193],"Pre-HCT":[194],"serology":[195],"available":[198],"91.1%":[200],"total":[203],"sample":[204],"(n=112).":[205],"Among":[206],"these,":[207],"88.4%":[208],"CMV":[210,215,277,286,295,304,390],"IgG-positive":[211,287],"6.3%":[213],"IgM-positive.":[216],"For":[217],"B,":[219],"2.7%":[220],"positive":[222,237,250,257,261],"both":[224],"anti-HBc":[225],"anti-HBs":[227],"(consistent":[228],"resolved":[230],"infection),":[231],"none":[232],"whom":[234],"HBV-NAT;":[238],"20.5%":[239],"isolated":[241],"Anti-HBs":[242,315],"positivity,":[243],"suggestive":[244],"vaccine-induced":[246],"immunity.":[247],"Anti-HCV":[248],"1.8%":[252],"patients,":[254],"no":[256],"HCV-NAT":[258],"results.":[259],"No":[260,309],"cases":[262],"identified":[264,373],"HTLV,":[268],"or":[269,331],"disease.":[271],"Age":[272],"differed":[273],"significantly":[274],"according":[275],"IgG":[278],"serostatus":[279],"(p":[280,319],"=":[281,320],"0.048),":[282],"being":[283],"higher":[284,303],"among":[285,294,306],"(61":[289],"years;":[290,299],"range,":[291,300],"26\u201375)":[292],"than":[293],"IgG-negative":[296],"(56.5":[298],"45\u201369),":[301],"indicating":[302,322,360],"seroprevalence":[305],"older":[307],"patients.":[308],"significant":[310],"association":[311],"found":[313],"positivity":[316],"0.764),":[321],"that":[323],"vaccination":[324,337,352],"coverage":[325],"low":[327,346],"regardless":[328],"incorporation":[333],"into":[338],"national":[340],"immunization":[341,365],"program.":[342],"Conclusion":[343],"We":[344],"observed":[345],"adherence":[347],"to/seroconversion":[348],"following":[349],"protocols":[353],"early":[356],"phase":[357],"treatment,":[359,384,418],"gap":[362],"strategy":[366],"MM.":[370],"Furthermore,":[371],"we":[372],"latent":[374],"viral":[375],"infections":[376],"potential":[378],"reactivation":[380],"post-HCT":[382],"immunotherapeutic":[383],"high":[387],"frequency":[388],"seropositivity":[391,396],"and,":[392],"lower":[394],"frequencies,":[395],"C":[401],"viruses.":[402],"These":[403],"findings":[404],"demonstrate":[405],"need":[407],"optimize":[409],"management":[412],"supporting":[419],"individualized":[420],"surveillance,":[421],"prevention":[425],"strategies.":[426]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}